GLIPR2 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84975
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of human GLIPR2. Peptide sequence: EVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKASASDGSS The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for GLIPR2 Antibody - BSA Free
![Western Blot: GLIPR2 Antibody [NBP2-84975]](https://resources.bio-techne.com/images/products/GLIPR2-Antibody-Western-Blot-NBP2-84975-img0001.jpg "Western Blot: GLIPR2 Antibody [NBP2-84975]")
Western Blot: GLIPR2 Antibody [NBP2-84975]
Western Blot: GLIPR2 Antibody [NBP2-84975] - Host: Rabbit. Target Name: C9orf19. Sample Type: Fetal Kidney lysates. Antibody Dilution: 1.0ug/mlApplications for GLIPR2 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GLIPR2
Alternate Names
C9orf19Glioma pathogenesis-related protein 2, chromosome 9 open reading frame 19, GAPR1, GAPR-117kD fetal brain protein, GLI pathogenesis-related 2, GliPR 2, Golgi-associated plant pathogenesis-related protein 1, Golgi-associated PR-1 protein
Gene Symbol
GLIPR2
Additional GLIPR2 Products
Product Specific Notices for GLIPR2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...